Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: Discussing a 74-year-old woman with diabetes, Dr Abrahamson1 noted that “ . . . no studies have evaluated the impact of intensive glucose control in individuals older than 60 years.”1 He could have added that no studies have evaluated the effect of intensive control with rosiglitazone or the effect of this combination of antidiabetic drugs. Nonetheless, when this patient taking a combination of metformin, glyburide, and rosiglitazone had a HbA1C value of 6.9%, the rosiglitazone dose was doubled, and the discussion centered on the variety of other drugs that can be added later when needed for intensive control.
Finucane TE. Intensive Glucose Control in Elderly Adults. JAMA. 2007;297(20):2195-2196. doi:10.1001/jama.297.20.2195-b